These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 19086953)

  • 1. High- versus low-dose proton pump inhibitors after endoscopic hemostasis in patients with peptic ulcer bleeding: a multicentre, randomized study.
    Andriulli A; Loperfido S; Focareta R; Leo P; Fornari F; Garripoli A; Tonti P; Peyre S; Spadaccini A; Marmo R; Merla A; Caroli A; Forte GB; Belmonte A; Aragona G; Imperiali G; Forte F; Monica F; Caruso N; Perri F
    Am J Gastroenterol; 2008 Dec; 103(12):3011-8. PubMed ID: 19086953
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proton pump inhibitors after endoscopic hemostasis in patients with peptic ulcer bleeding.
    Mesihovic R; Vanis N; Mehmedovic A; Gornjakovic S; Gribajcevic M
    Med Arh; 2009; 63(6):323-7. PubMed ID: 20380111
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of intravenous proton pump inhibitor regimens and timing of endoscopy on clinical outcomes of peptic ulcer bleeding.
    Liu N; Liu L; Zhang H; Gyawali PC; Zhang D; Yao L; Yang Y; Wu K; Ding J; Fan D
    J Gastroenterol Hepatol; 2012 Sep; 27(9):1473-9. PubMed ID: 22646140
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Randomised clinical trial: high-dose vs. standard-dose proton pump inhibitors for the prevention of recurrent haemorrhage after combined endoscopic haemostasis of bleeding peptic ulcers.
    Chen CC; Lee JY; Fang YJ; Hsu SJ; Han ML; Tseng PH; Liou JM; Hu FC; Lin TL; Wu MS; Wang HP; Lin JT
    Aliment Pharmacol Ther; 2012 Apr; 35(8):894-903. PubMed ID: 22369682
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hematologic and laboratory parameters in patientis with peptic ulcer bleeding treated by two modalities of endoscopic haemostasis and proton pump inhibitors.
    Mehmedović-Redzepović A; Mesihović R; Prnjavorac B; Kulo A; Merlina K
    Med Glas (Zenica); 2011 Feb; 8(1):151-7. PubMed ID: 21263414
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of intravenous omeprazole in patients with high-risk peptic ulcer bleeding after successful endoscopic epinephrine injection: a prospective randomized comparative trial.
    Lin HJ; Lo WC; Cheng YC; Perng CL
    Am J Gastroenterol; 2006 Mar; 101(3):500-5. PubMed ID: 16542286
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of an intravenous proton pump inhibitor after endoscopic therapy with epinephrine injection for peptic ulcer bleeding in patients with uraemia: a case-control study.
    Tseng GY; Fang CT; Lin HJ; Yang HB; Tseng GC; Wang PC; Liao PC; Cheng YT; Huang CH
    Aliment Pharmacol Ther; 2009 Aug; 30(4):406-13. PubMed ID: 19485981
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of intravenous omeprazole on recurrent bleeding after endoscopic treatment of bleeding peptic ulcers.
    Lau JY; Sung JJ; Lee KK; Yung MY; Wong SK; Wu JC; Chan FK; Ng EK; You JH; Lee CW; Chan AC; Chung SC
    N Engl J Med; 2000 Aug; 343(5):310-6. PubMed ID: 10922420
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Randomized controlled trial of high dose bolus versus continuous intravenous infusion pantoprazole as an adjunct therapy to therapeutic endoscopy in massive bleeding peptic ulcer.
    Yamada S; Wongwanakul P
    J Med Assoc Thai; 2012 Mar; 95(3):349-57. PubMed ID: 22550833
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current managements and outcomes of peptic and artificial ulcer bleeding in Japan.
    Fujishiro M; Abe N; Endo M; Kawahara Y; Shimoda R; Nagata S; Homma K; Morita Y; Uedo N
    Dig Endosc; 2010 Jul; 22 Suppl 1():S9-14. PubMed ID: 20590780
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of programmed endoscopic follow-up examinations on the rebleeding rate of gastric or duodenal peptic ulcers treated by injection therapy: a prospective, randomized controlled trial.
    Messmann H; Schaller P; Andus T; Lock G; Vogt W; Gross V; Zirngibl H; Wiedmann KH; Lingenfelser T; Bauch K; Leser HG; Schölmerich J; Holstege A
    Endoscopy; 1998 Sep; 30(7):583-9. PubMed ID: 9826134
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnosis and management of nonvariceal upper gastrointestinal hemorrhage: European Society of Gastrointestinal Endoscopy (ESGE) Guideline.
    Gralnek IM; Dumonceau JM; Kuipers EJ; Lanas A; Sanders DS; Kurien M; Rotondano G; Hucl T; Dinis-Ribeiro M; Marmo R; Racz I; Arezzo A; Hoffmann RT; Lesur G; de Franchis R; Aabakken L; Veitch A; Radaelli F; Salgueiro P; Cardoso R; Maia L; Zullo A; Cipolletta L; Hassan C
    Endoscopy; 2015 Oct; 47(10):a1-46. PubMed ID: 26417980
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of intravenous and oral esomeprazole in the prevention of recurrent bleeding from peptic ulcers after endoscopic therapy.
    Sung JJ; Suen BY; Wu JC; Lau JY; Ching JY; Lee VW; Chiu PW; Tsoi KK; Chan FK
    Am J Gastroenterol; 2014 Jul; 109(7):1005-10. PubMed ID: 24777150
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-dose omeprazole infusion compared with scheduled second-look endoscopy for prevention of peptic ulcer rebleeding: a randomized controlled trial.
    Chiu PW; Joeng HK; Choi CL; Tsoi KK; Kwong KH; Lam SH; Sung JJ
    Endoscopy; 2016 Aug; 48(8):717-22. PubMed ID: 27275859
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety and tolerability of high-dose intravenous esomeprazole for prevention of peptic ulcer rebleeding.
    Kuipers EJ; Sung JJ; Barkun A; Mössner J; Jensen D; Stuart R; Lau JY; Ahlbom H; Lind T; Kilhamn J
    Adv Ther; 2011 Feb; 28(2):150-9. PubMed ID: 21181319
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of hemostatic efficacy for epinephrine injection alone and injection combined with hemoclip therapy in treating high-risk bleeding ulcers.
    Lo CC; Hsu PI; Lo GH; Lin CK; Chan HH; Tsai WL; Chen WC; Wu CJ; Yu HC; Cheng JS; Lai KH
    Gastrointest Endosc; 2006 May; 63(6):767-73. PubMed ID: 16650535
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proton-pump inhibitors and outcome of endoscopic hemostasis in bleeding peptic ulcers: a series of meta-analyses.
    Andriulli A; Annese V; Caruso N; Pilotto A; Accadia L; Niro AG; Quitadamo M; Merla A; Fiorella S; Leandro G
    Am J Gastroenterol; 2005 Jan; 100(1):207-19. PubMed ID: 15654802
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of p.o. or i.v. proton pump inhibitors on 72-h intragastric pH in bleeding peptic ulcer.
    Javid G; Zargar SA; U-Saif R; Khan BA; Yatoo GN; Shah AH; Gulzar GM; Sodhi JS; Khan MA
    J Gastroenterol Hepatol; 2009 Jul; 24(7):1236-43. PubMed ID: 19682194
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Diagnosis and treatment of bleeding peptic ulcer: our experience].
    Zippi M; Febbraro I; De Felici I; Mattei E; Traversa G; Occhigrossi G
    Clin Ter; 2008; 159(4):249-55. PubMed ID: 18776982
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intragastric pH with oral vs intravenous bolus plus infusion proton-pump inhibitor therapy in patients with bleeding ulcers.
    Laine L; Shah A; Bemanian S
    Gastroenterology; 2008 Jun; 134(7):1836-41. PubMed ID: 18423628
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.